← Back to Search

Cardiovascular Risk Assessment for Rheumatoid Arthritis (CARE RA Trial)

N/A
Waitlist Available
Led By Iris Navarro-Milan, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age between 40 and 75 years (inclusive)
Be older than 18 years old
Must not have
Do not have rheumatoid arthritis
Younger than age 40 or older than age 75
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-intervention

Summary

This trial will develop an intervention to improve lipid screening and management in RA patients in order to decrease the risk for heart attacks and strokes.

Who is the study for?
This trial is for US residents aged 40-75 with Rheumatoid Arthritis who haven't had a cholesterol test in the past 2 years or discussed results with a doctor. Participants must speak English, have a phone and internet access, and be willing to work with a peer coach.
What is being tested?
The study tests an intervention aimed at improving cholesterol screening and management in RA patients. It involves patient education and decision support programs to help reduce heart attack and stroke risk by managing high cholesterol.
What are the potential side effects?
Since this trial focuses on cardiovascular risk assessment rather than medication, it does not directly involve drug-related side effects. However, any new interventions may cause stress or anxiety related to health awareness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 40 and 75 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have rheumatoid arthritis.
Select...
I am under 40 or over 75 years old.
Select...
I have a history of heart disease.
Select...
I am currently taking a statin medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of subjects screened for hyperlipidemia
Number of subjects who initiated a statin
Secondary study objectives
General Self-Efficacy Scale (GSF) score
Medication Understanding and Use Self-Efficacy Scale (MUSE) score
Patient Activation Measure (PAM) score - 13 item
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Peer coach guided online learning programExperimental Treatment1 Intervention
Group II: Self-administered online learning programPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,085 Previous Clinical Trials
1,147,243 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
496 Previous Clinical Trials
1,089,433 Total Patients Enrolled
44 Trials studying Rheumatoid Arthritis
560,879 Patients Enrolled for Rheumatoid Arthritis
Iris Navarro-Milan, MDPrincipal InvestigatorWeill Medical College of Cornell University

Media Library

Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis Clinical Trial Eligibility Overview. Trial Name: NCT04488497 — N/A
Rheumatoid Arthritis Research Study Groups: Peer coach guided online learning program, Self-administered online learning program
Rheumatoid Arthritis Clinical Trial 2023: Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis Highlights & Side Effects. Trial Name: NCT04488497 — N/A
Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis 2023 Treatment Timeline for Medical Study. Trial Name: NCT04488497 — N/A
~17 spots leftby Nov 2025